Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -95.29 | 19.60 |
| PEG Ratio (TTM) | 0.22 | -3.02 |
| P/S Ratio (TTM) | 1.55 | 2.01 |
| P/B Ratio (TTM) | 1.74 | 4.12 |
| P/FCF Ratio (TTM) | -9.92 | 10.51 |
| Price to 5YR AVG Earnings Ratio | N/A | 22.59 |
| Price to 5YR AVG FCF Ratio | N/A | -32.20 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.47% | 3.02% |
| ROE (TTM) | -1.80% | 11.43% |
| Net Profit Margin (TTM) | -1.62% | 0.63% |
| ROIC 5YR AVG | N/A | 9.06% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -2,859.44% | 50.21% | N/A |
| Revenue | 0.54% | -3.91% | N/A |
| Net Income | -2,947.39% | 31.07% | N/A |
| Cash Flow | 10.22% | 15.92% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.87 | 0.84 |
| Quick Ratio (TTM) | 0.87 | 0.79 |
| D/E Ratio (TTM) | 2.19 | 1.67 |
| Interest Coverage (TTM) | 0.66 | 6.78 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 0.83 | 1.08 |
| LTL to 5YR AVG FCF | N/A | -9.12 |
| Shares Outstanding Growth 5YR AVG | N/A | 0.36% |